孤独症谱系障碍遗传学与病理机制探索
本文综述了孤独症谱系障碍(ASD)基因与基因组区域识别的最新进展,指出风险基因列表可靠且快速增长,编码蛋白指向少数生物学领域,中胎儿前额叶皮层发育是高效力风险基因的脆弱节点,为理性治疗开发提供多条路径。
要点
- ASD风险基因列表可靠且快速增长,推动对遗传风险和ASD生物学的理解。
- 编码蛋白指向少数生物学领域,神经科学与功能基因组学进展带来深刻见解。
- 中胎儿前额叶皮层发育是部分高效力ASD风险基因的脆弱汇聚点。
核心结论
- ASD遗传学进展虽未改变临床实践,但为病理机制理解和理性治疗开发带来切实乐观。
研究设计与样本
- 本文为综述,检索范围未在原文中具体报告。
主要发现
- 可靠的风险基因列表规模大且快速增长。
- 已识别的编码蛋白指向相对少数的生物学领域。
- 有强证据指向中胎儿前额叶皮层发育是部分高效力ASD风险基因的脆弱汇聚点。
- 存在多条通往理性治疗开发的可行路径,虽具挑战但根本区别于基因发现成功之前。
临床怎么用
- 当前遗传学发现尚未对临床实践产生变革性影响。
局限性
- 原文未系统报告综述的检索范围与纳入标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent progress in the identification of genes and genomic regions contributing to autism spectrum disorder (ASD) has had a broad impact on our understanding of the nature of genetic risk for a range of psychiatric disorders, on our understanding of ASD biology, and on defining the key challenges now facing the field in efforts to translate gene discovery into an actionable understanding of pathology. While these advances have not yet had a transformative impact on clinical practice, there is nonetheless cause for real optimism: reliable lists of risk genes are large and growing rapidly; the identified encoded proteins have already begun to point to a relatively small number of areas of biology, where parallel advances in neuroscience and functional genomics are yielding profound insights; there is strong evidence pointing to mid-fetal prefrontal cortical development as one nexus of vulnerability for some of the largest-effect ASD risk genes; and there are multiple plausible paths forward toward rational therapeutics development that, while admittedly challenging, constitute fundamental departures from what was possible prior to the era of successful gene discovery.
引用
- Manoli DS, State MW. Autism Spectrum Disorder Genetics and the Search for Pathological Mechanisms. Am J Psychiatry. 2021. PMID: 33384012. doi:10.1176/appi.ajp.2020.20111608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。